Search details
1.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Article
in English
| MEDLINE | ID: mdl-35660812
2.
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
Blood
; 139(17): 2706-2711, 2022 04 28.
Article
in English
| MEDLINE | ID: mdl-35134127
3.
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
Blood
; 137(4): 556-568, 2021 01 28.
Article
in English
| MEDLINE | ID: mdl-33104215
4.
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Cancer
; 127(1): 82-92, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-32966625
5.
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Cancer
; 127(4): 609-618, 2021 02 15.
Article
in English
| MEDLINE | ID: mdl-33085090
6.
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
Biol Blood Marrow Transplant
; 26(6): 1137-1143, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32062061
7.
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(8): 1459-1468, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32434056
8.
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
Biol Blood Marrow Transplant
; 26(9): 1747-1756, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32464284
9.
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 26(11): 2139-2146, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32781289
10.
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
Biol Blood Marrow Transplant
; 26(6): 1210-1217, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32088366
11.
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Cancer
; 126(10): 2279-2287, 2020 05 15.
Article
in English
| MEDLINE | ID: mdl-32049359
12.
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Haematologica
; 105(5): 1329-1338, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31558669
13.
Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.
Biol Blood Marrow Transplant
; 25(6): 1099-1106, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30794931
14.
Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.
Biol Blood Marrow Transplant
; 25(2): 270-278, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30292009
15.
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 25(1): 73-85, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30153491
16.
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(5): e145-e154, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30521975
17.
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(9): 1875-1883, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31085303
18.
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(9): 1744-1755, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31158502
19.
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
Biol Blood Marrow Transplant
; 25(7): 1325-1330, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30716454
20.
Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis.
Am J Transplant
; 19(10): 2900-2909, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31152491